TrialClinical lymphoma, myeloma & leukemia2020

Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study.

Chutima Kunacheewa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.